Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective.

Front Neurol · 2023 · PMC10229878 · PMID 37265469

Europe PMC DOI

hedged sentence

0.0626

closest p · 1.3× alpha

0.0626

boldest claim

The sentences

borderline significantp = 0.0626so close (0.05 < p ≤ 0.1)

Hence, avalglucosidase alfa therapy is considered to provide better outcomes over alglucosidase alfa even though testing for superiority was borderline significant ( p = 0.0626) ( 60 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.